Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Clinical trial NCT05364671 · COMPLETED

Trial details

NCT number: NCT05364671
Sponsor: Materia Medica Holding
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronavirus Disease 2019 (COVID-19)

Start date: 2022-04-29
Primary completion: 2023-08-18
Enrollment: 771

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.